Approval · Notice of Compliance 1086 · 2000
BONEFOS: Notice of Compliance 1086
Issued October 20, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1086
- Date
- October 20, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Bone metabolism regulator (anti-hypercalcemia agent)
Products in this notice
Medicinal ingredients
- DISODIUM CLODRONATE TETRAHYDRATE 400 MG per CAP
- DISODIUM CLODRONATE TETRAHYDRATE 60 MG per ML